https://www.bloomberg.com/news/articles/2022-08-31/musk-wants-longer-twitter-trial-delay-over-whistle-blower-claims?utm_content=tech&utm_campaign=socialflow-organic&utm_source=twitter&utm_medium=lawdesk&cmpid=socialflow-twitter-business&cmpid%3D=socialflow-twitter-tech&campaign=1E81ACA0-2950-11ED-B083-4BDC4F017A06
Hoth Therapeutics Announces Expansion Of FDA Cleared First-In-Human Clinical Trial For Cancer Patients Of HT-001 At University Of Miami For The Treatment Of Skin Toxicities Associated With EGFRi Treatments
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, announced today that it has received approval from the University of Miami to enroll patients for its first in human clinical
